News, stories & comment

Boehringer_Ingelheim Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib*

26 January 2012
Boehringer Ingelheim announced the initiation of two phase III clinical trials...

Merck logo New FDA approved labeling for VYTORIN® (Ezetimibe/Simvastatin)

25 January 2012
The FDA has approved an updated label for VYTORIN® (ezetimibe/simvastatin)...

Roche logo Roche offers to acquire all outstanding shares of Illumina, Inc. to further strengthen its leading role in diagnostics

25 January 2012
Roche announced that it is proposing to acquire all outstanding shares of Illumina, Inc...

SANOFI logo Genzyme announces FDA approval of Framingham manufacturing plant

24 January 2012
The FDA has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta)...

Eli Lilly logo Elanco Animal Health announces Lilly’s agreement to acquire ChemGen Corp.

24 January 2012
Elanco, announced that Lilly has signed an agreement to acquire ChemGen Corp., a privately held bioscience company...

Subscriptions & membership

Become a subscriber today for just £90 and receive:

  • the next six issues of European Pharmaceutical Review magazine,
  • online access to hundreds of articles from our back issue archive, and much more...

And if you subscribe for 2 years you'll save 25%!

Subscribe today >>

Request trial subscription >>

Articles by topic

Browse our magazine back issue archive by topic: